An interventional study of Drug balloon dilatation and Direct vision internal urethrotomy (DVIU) in Urethral Stricture Less Than 2 cm, sponsored by Lepu Medical Technology (Beijing) Co., Ltd.. Status unknown at 1 site in China. Open to male participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2023-04-13.
Sponsored by Lepu Medical Technology (Beijing) Co., Ltd. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
To evaluate the safety and efficacy of urethral drug balloon catheter in the treatment of urethral stricture.
This is a prospective, multicenter, randomized controlled, and superiority study. The two groups were randomly selected into a total of 150 subjects (75 in the test group and 75 in the control group) according to 1:1. The test group was treated with urethral drug balloon catheter from Lepu Medical Technology (Beijing) Co.,Ltd., while the control group was treated with direct vision internal urethrotomy (DVIU).
All subjects were followed up at 1, 3 and 6 months post-procedure, and the efficacy of urethral drug balloon catheter will be evaluated with the success rate of operation at 6 months as the main end point. Observe the occurrence of complications and other indicators to make a reliable evaluation of the safety of urethral drug balloon catheter.
72 studies on the registry are indexed under Urethral Stricture; 25 are open to participants now.
This study's planned enrollment of 150 is above the median of 60 across 56 interventional studies indexed under Urethral Stricture.
Browse Urethral Stricture studies →Lepu Medical Technology (Beijing) Co., Ltd. is the lead sponsor of 15 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age ≥ 18 and ≤ 85 years old, male patients;
Exclusion Criteria:
Patients with multiple stenotic lesions;
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The test arm will be the treated by Drug Balloon
Procedure: Drug balloon dilatation
The control arm will be treated by Direct vision internal urethrotomy (DVIU)
Procedure: Direct vision internal urethrotomy (DVIU)
The Drug balloon is covered with paclitaxel coating that diffuses the drug into the urethral wall when dilated
A control subject will choose DVIU surgery until the desired effect is achieved
Procedural success
no reoperation or instrument intervention is required, and 16F bladder flexible mirror or 16F catheter can pass through the stenosis
Time frame: 6 months post-procedure
Change in the International Prostate Symptom Score (IPSS)
Time frame: 1, 3 and 6months
Change in the Quality of life index score (QOL)
Time frame: 1, 3 and 6months
Maximum urinary flow rate (Qmax)
Time frame: 1 and 6 months post-procedure
Residual urine volume (PVR)
Time frame: 6 months post-procedure
Postoperative complications
bleeding, false passage formation, rectal injury, infection, etc
Time frame: 1,3,6 months post-procedure
Number of re-interventions after operation
Time frame: 1, 3, 6 months post-procedure
Started Mar 2022 (actual). Primary completion is estimated for Oct 2024, 31 months after the start.
Of 24 interventional studies with no phase under Urethral Stricture, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 64. This study's planned 31 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lepu Medical Technology (Beijing) Co., Ltd. →